Treatment of unresectable hepatocellular carcinoma with lipiodol chemoembolization: a multicenter randomized trial
- 1 July 1998
- journal article
- clinical trial
- Published by Elsevier in Journal of Hepatology
- Vol. 29 (1), 129-134
- https://doi.org/10.1016/s0168-8278(98)80187-6
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Comparison of resection, liver transplantation and transcatheter oily chemoembolization in treatment of hepatocellular carcinomaJournal of Hepatology, 1996
- Chemoembolisation with lipiodol and doxorubicin: applicability in British patients with hepatocellular carcinoma.Gut, 1996
- Treatment of hepatocellular carcinoma with tamoxifen: A double-blind placebo-controlled trial in 120 patientsGastroenterology, 1995
- A Comparison of Lipiodol Chemoembolization and Conservative Treatment for Unresectable Hepatocellular CarcinomaNew England Journal of Medicine, 1995
- Controlled trial of tamoxifen in patients with advanced hepatocellular carcinomaJournal of Hepatology, 1994
- Transarterial oily chemoembolization for the treatment of hepatocellular carcinoma: A multivariate analysis of prognostic factorsHepatology, 1994
- Primary treatment of hepatocellular carcinoma by arterial chemoembolizationThe American Journal of Surgery, 1992
- Transcatheter oily chemoembolization in the management of advanced hepatocellular carcinoma in cirrhosis: Results of a western comparative study in 60 patientsHepatology, 1991
- Unresectable hepatocellular carcinoma: a prospective controlled trial with tamoxifenJournal of Hepatology, 1990
- A randomized trial of hepatic arterial chemoembolization in patients with unresectable hepatocellular carcinomaJournal of Hepatology, 1990